Company intelligence / Profile preview

Artemis Dx

Ownership: Private
Development stage: Commercial

Overview

Artemis Dx is an active consulting and contract development/manufacturing organization specializing in in vitro diagnostics, particularly point-of-care immunoassays, molecular assays, and microfluidic assays. The company offers expertise from concept to manufacturing for diagnostic products but does not have its own clinical pipeline or therapeutic programs.

Therapeutic areas: Other
Modalities: ImmunoassayMolecular assayMicrofluidic assayPoint-of-care assay
Industry: Consulting

Partnerships

Not publicly disclosed

Beyond the preview

Go deeper on Artemis Dx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Artemis Dx.

Explore the full profile